Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

531
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
531
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

530
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
530
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolutionarily informed gene sets reveal conserved and lineage-modified transcriptional programs during vertebrate forebrain evolution.

bioRxiv : the preprint server for biology·2026
Same author

Deconvolving cell-type-specific gene expression profiles from bulk RNA-seq samples.

PLoS computational biology·2026
Same author

Programming T cells for Early Cancer Detection with Customized Protease-Activatable Receptors.

bioRxiv : the preprint server for biology·2026
Same author

Recursive Clustering of Cellular Diversity in scRNA-Seq Data.

Journal of computational biology : a journal of computational molecular cell biology·2025
Same author

AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity.

Nature nanotechnology·2025
Same author

Hierarchical marker genes selection in scRNA-seq analysis.

PLoS computational biology·2024

Related Experiment Video

Updated: Jan 7, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Clustering Analysis of Multiple Omics Data Types Identifies Cancer Patients With Consistent Survival Outcomes.

Shuting Lin1, Peng Qiu2

  • 1School of Biological Sciences, Georgia Institute of Technology, Atlanta, USA.

Cancer Informatics
|December 29, 2025
PubMed
Summary

This study shows that clustering cancer patient data from different omics layers, like gene expression, can identify distinct patient groups with significantly different survival outcomes. Consistent patient clusters across multiple omics types reveal key molecular features linked to cancer prognosis.

Keywords:
TCGAcancer subtypeclustering analysismulti-omicssurvival analysis

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.9K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K

Related Experiment Videos

Last Updated: Jan 7, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.9K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.1K

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Cancer stratification is crucial for personalized treatment and prognosis.
  • Integrating multiple omics data types aids in identifying cancer subtypes.
  • The comparative ability of individual omics layers to define survival-related patient clusters is not well understood.

Purpose of the Study:

  • To examine patient clusters defined by different omics data types (miRNA expression, gene expression, DNA methylation).
  • To explore the consistency of these clusters across omics layers.
  • To assess the association of these clusters with patient survival outcomes.

Main Methods:

  • Clustering analysis was performed on miRNA, gene expression, and DNA methylation data from 20 cancer types in TCGA.
  • A standard clustering pipeline, similar to Seurat, was employed.
  • Survival analysis was conducted to evaluate survival differences among patient clusters.

Main Results:

  • Significant survival differences were observed in patient clusters across 11 cancer types.
  • In 6 cancer types, survival differences were significant in multiple omics data types.
  • A consistent set of patients, irrespective of omics data type, showed the most favorable or unfavorable survival outcomes, indicating distinct multi-omics expression patterns.

Conclusions:

  • Omics-specific clustering effectively identifies robust survival-related patient clusters.
  • This approach can uncover molecular features contributing to differential survival outcomes.
  • Consistent multi-omics clustering highlights patient groups with distinct survival patterns.